Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Windtree Therapeutics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −17 vs. Q4 2022
- Shares held
- 2.57K
- −1.62M (−99.8%) vs. Q4 2022
- Total value
- $12.8K
- −$260.7K (−95.3%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 17
- 8 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WINT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 5 | $8.75K |
| Q1 2025 | 5 | $57.0K |
| Q4 2024 | 15 | $108.7K |
| Q3 2024 | 8 | $389.7K |
| Q2 2024 | 5 | $4.87K |
| Q1 2024 | 9 | $238.8K |
| Q4 2023 | 12 | $194.1K |
| Q3 2023 | 12 | $197.7K |
| Q2 2023 | 12 | $151.7K |
| Q1 2023 | 9 | $12.8K |
| Q4 2022 | 27 | $276.6K |
| Q3 2022 | 27 | $518.7K |
| Q2 2022 | 25 | $664.4K |
| Q1 2022 | 27 | $1.76M |
| Q4 2021 | 26 | $2.72M |
| Q3 2021 | 19 | $3.02M |
| Q2 2021 | 27 | $3.94M |
| Q1 2021 | 21 | $2.72M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Windtree Therapeutics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,201 | $6.00K | 0.00% | −17,363−93.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 1,000 | $4.99K | 0.00% | −49,000−98.0% | Reduced |
| UBS Group AG | 357 | $1.78K | 0.00% | −10−2.7% | Reduced |
| IFP Advisors, Inc | 6 | $23 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4 | $20 | 0.00% | −1,312−99.7% | Reduced |
| Advisor Group Holdings, Inc. | 1 | $5 | 0.00% | −46,356−100.0% | Reduced |
| Morgan Stanley | 1 | $5 | 0.00% | −38−97.4% | Reduced |
| Gradient Investments LLC | 1 | $5 | 0.00% | −22−95.7% | Reduced |
| Parallel Advisors, LLC | 1 | $5 | 0.00% | −10−90.9% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −335,700−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −212,236−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −187,060−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −168,233−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −158,747−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −110,500−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −84,420−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −50,176−100.0% | Sold out |
| Rockwood Wealth Management, LLC | 0 | $0 | 0.00% | −35,101−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −29,795−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −32,999−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,693−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −20,270−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,949−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −10,299−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | – | – | – | – | Not filed |